Large gap with delayed quotes
|
Last quote
12/15/2025
-
22:15:00
|
Bid
12/15/2025 -
21:59:59
|
Bid Volume |
Ask
12/15/2025 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
11.28
-0.25
(
-2.17% )
|
11.26
|
300 |
11.28
|
39,100 |
Analysis date: 12.12.2025
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 01.08.2025.
Interest
Weak
Weak
Two stars since 09.12.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 12.08.2025 at a price of 13.47.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 04.11.2025.
4wk Rel Perf
35.61%
35.61%
The four-week dividend-adjusted overperformance versus SP500 is 35.61%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 15.07.2025.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 1.87%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 5.93%.
Mkt Cap in $bn
1.48
1.48
With a market capitalization <$2bn, BIOHAVEN LTD. is considered a small-cap stock.
G/PE Ratio
2.46
2.46
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
-5.77
-5.77
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
14.16%
14.16%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
120
120
For 1% of index variation, the stock varies on average by 1.20%.
Correlation
0.29
0.29
Stock movements are strongly independent of index variations.
Value at Risk
8.45
8.45
The value at risk is estimated at USD 8.45. The risk is therefore 73.30%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
15.07.2025
15.07.2025